Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03323086 · ClinicalTrials.gov registry record · NA
Women SHARE Study: Reducing Sexual Risk
A NA study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03323086: Completed NA study, sponsored by The Miriam Hospital.
NCT03323086 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03323086, a NA study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will investigate whether BI and technology extenders are feasible and acceptable for female patients at a reproductive health center (ages 18-29).
Primary Outcome
percentage of individuals who attended their intervention
Interventions
- OTHER Brochure
- BEHAVIORAL Brief Intervention (BI) with Technology Extender
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-10-18 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
What the finished NCT03323086 record still lists
NCT03323086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Brochure is the first listed.
NCT03323086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03323086 about?
NCT03323086 is a clinical study titled "Women SHARE Study: Reducing Sexual Risk". This study will investigate whether BI and technology extenders are feasible and acceptable for female patients at a reproductive health center (ages 18-29).
What is the current status of trial NCT03323086?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-10-18. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT03323086?
The interventions under investigation include: Brochure (OTHER), Brief Intervention (BI) with Technology Extender (BEHAVIORAL).
Who is sponsoring clinical trial NCT03323086?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03323086's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI